EP0503702B1 - Röntgenschirm mit randverstärkender Schicht - Google Patents

Röntgenschirm mit randverstärkender Schicht Download PDF

Info

Publication number
EP0503702B1
EP0503702B1 EP19920200528 EP92200528A EP0503702B1 EP 0503702 B1 EP0503702 B1 EP 0503702B1 EP 19920200528 EP19920200528 EP 19920200528 EP 92200528 A EP92200528 A EP 92200528A EP 0503702 B1 EP0503702 B1 EP 0503702B1
Authority
EP
European Patent Office
Prior art keywords
phosphor
coating
screen
radiographic
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP19920200528
Other languages
English (en)
French (fr)
Other versions
EP0503702A1 (de
Inventor
Jan Emiel Van Havenbergh
Jozef René Aertbelien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agfa Gevaert NV
Original Assignee
Agfa Gevaert NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agfa Gevaert NV filed Critical Agfa Gevaert NV
Priority to EP19920200528 priority Critical patent/EP0503702B1/de
Publication of EP0503702A1 publication Critical patent/EP0503702A1/de
Application granted granted Critical
Publication of EP0503702B1 publication Critical patent/EP0503702B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21K—TECHNIQUES FOR HANDLING PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES
    • G21K4/00—Conversion screens for the conversion of the spatial distribution of X-rays or particle radiation into visible images, e.g. fluoroscopic screens
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21K—TECHNIQUES FOR HANDLING PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES
    • G21K4/00—Conversion screens for the conversion of the spatial distribution of X-rays or particle radiation into visible images, e.g. fluoroscopic screens
    • G21K2004/02—Conversion screens for the conversion of the spatial distribution of X-rays or particle radiation into visible images, e.g. fluoroscopic screens characterised by the external panel structure
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21K—TECHNIQUES FOR HANDLING PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES
    • G21K4/00—Conversion screens for the conversion of the spatial distribution of X-rays or particle radiation into visible images, e.g. fluoroscopic screens
    • G21K2004/10—Conversion screens for the conversion of the spatial distribution of X-rays or particle radiation into visible images, e.g. fluoroscopic screens with a protective film
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21K—TECHNIQUES FOR HANDLING PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES
    • G21K4/00—Conversion screens for the conversion of the spatial distribution of X-rays or particle radiation into visible images, e.g. fluoroscopic screens
    • G21K2004/12—Conversion screens for the conversion of the spatial distribution of X-rays or particle radiation into visible images, e.g. fluoroscopic screens with a support

Definitions

  • the present invention relates to radiographic screens for use in medical diagnosis, more in particular it relates to radiation cured coatings suitable for reinforcing the edges of a radiographic screen.
  • an X-ray image is obtained by irradiating X-rays transmitted through a subject on an X-ray conversion screen containing on a support a layer of fluorescent phosphor which absorbs X-rays and converts them into visible light and/or ultraviolet radiation when struck by X-rays; said visible light then irradiates a film coated with a silver halide emulsion layer which is subsequently developed.
  • the X-ray films which are used generally comprise a transparent film support coated on each of its faces with a silver halide emulsion layer.
  • Two X-ray conversion screens are usually employed, one positioned on each side of the double-side coated film; the film together with the two screens are usually encased in a suitable cassette. Combinations of single emulsion films with single screens are often used in high definition applications (extremities, mammography).
  • X-ray radiation transmitted through a subject is irradiated on a stimulable phosphor layer of a stimulable X-ray conversion screen to accumulate radiation energy corresponding to the radiation transmission degrees at respective portions of the subject and forming a latent image, then the stimulable phosphor layer is scanned with a stimulating excitation light, thereby releasing the radiation energy stored at the respective portions as light emission, and subsequently an image is obtained according to the optical signals depending on the intensity of the emitted light.
  • the image may be processed and the obtained final image may be reproduced as a hard copy or reproduced on CRT.
  • the stimulable phosphor sheet does not serve to finally record image information, but only stores the information temporarily to provide the image or the like on an independently prepared final recording medium. Accordingly, the stimulable phosphor sheet can, after being erased, be repeatedly used.
  • X-ray conversion screens comprise, in order, a support, an active layer comprising a fluorescent phosphor dispersed in a suitable binder and a protective topcoat or abrasion layer coated over the active layer to protect said active layer during use.
  • the term X-ray conversion screens, fluorescent phosphor and the like as used herein refers to screens, phosphors or the like for use in conventional screen-film combinations as well as to stimulable screens, phosphors or the like.
  • each radiographic screen is used frequently, it is important to provide them with an adequate topcoat effectively protecting the active layer from physical and chemical deterioration. This is particularly important in stimulable radiographic screens where the screen is not encased in a cassette but is used and handled as such.
  • radiographic screens may be conventionally edge-reinforced with materials such as cellulose acetobutyrate, nitrocellulose acrylate or resins such as vinyl acetate resin and vinyl chloride resin, acting as abrasion resistant material.
  • materials such as cellulose acetobutyrate, nitrocellulose acrylate or resins such as vinyl acetate resin and vinyl chloride resin, acting as abrasion resistant material.
  • the repeated use in a continuous cycle of exposing the stimulable phosphor screen to radiation, reading out the radiation image recorded therein, and removing the remaining radiation energy in the screen implies moving the screen through the various processing stations.
  • edge-reinforcement of stimulable phosphor screens such as described e.g. in EP-A-83470, comprising coating the edge faces of a stimulable phosphor screen with a polymer material comprising polyurethane or acrylic resin
  • edge-reinforcement is performed by dissolving the polymer material in a suitable solvent to prepare a solution of the polymer material (edge-reinforcing solution) applying the solution to the edge faces of the screen and then drying the coating of the solution.
  • the removal of said solvents by evaporation causes an additional lengthy drying step during the manufacture of the screens and implies also ecological problems.
  • edge-reinforcements based upon such coatings do not yield satisfactory results.
  • edge-reinforcement of radiographic screens by applying radiation curable compositions appears to be an appropriate solution. From the point of view of mechanical strength and abrasion resistance radiation curable compositions are preferred over the more conventional protective coatings.
  • the adhesion of the radiation curable compositions to the edges of the radiographic screens causes problems. Due to the numerous shocks and rough handling of the screens, in particular the stimulable phosphor screens, edge-reinforcements based upon radiation curable coatings are easily damaged, and tend not to adhere firmly any more to the edges of the screen.
  • the edge reinforcing coating should exhibit good adhesive properties towards chemically quite distinct materials; the edges of the phosphor layer itself, comprising inorganic phosphor pigments cemented by a small amount of an organic binder medium, optionally a radiation cured protective topcoat, and the thermoplastic film support, usually made of polyethyleneterephthalate.
  • the radiation curable coating compositions described in the prior art show poor adhesion properties to either the protective topcoat, either the phosphor/binder mixture, and/or the thermoplastic film support of the radiographic screen. Due to this poor adhesion, the benefits of the inherent high abrasion resistance and mechanical strength of an edge reinforcing coating based upon a radiation curable composition are lost.
  • a radiographic screen the edges whereof are reinforced by a radiation cured composition exhibiting good adhesive properties to the phosphor layer, a radiation cured protective coating on top of said phosphor layer, and the thermoplastic film support made of e.g. polyethylene terephthalate.
  • a radiographic screen comprising a support, a layer comprising a fluorescent phosphor dispersed in a binder and a protective topcoat coated over the phosphor layer, characterised in that the edges of the screen are reinforced by a radiation cured coating obtained by curing a radiation curable composition comprising a polyester as prepolymer, and a diluent mono-functional monomer.
  • said radiographic screen is in addition characterised in that its edges are reinforced by a radiation cured coating obtained by curing a radiation curable composition comprising a copolymer of ethylene terephthalate/isophthalate as polyester and a methacrylate, preferably methylmethacrylate or tetrahydrofurfurylmethacrylate, as mono-functional diluent monomer.
  • the radiation curable composition suitable for edge-reinforcing the radiographic screen according to our invention contains a polyester prepolymer, a reactive diluent mono-functional monomer and in the case of an UV curable formulation a photoinitiator.
  • the usual amounts of these primary components are 30-100 % by weight for the prepolymer, 10-70 % by weight for the reactive diluent and 0-10 % by weight for the photoinitiator.
  • additives may be added in an amount of 0-10 % by weight.
  • additives may be used surfactants, waxes, defoamers, plasticizers and stabilizers. Pigments may be added in an amount of 0-60 % by weight.
  • polyester prepolymer there may be exemplified the following: unsaturated polyesters; modified unsaturated polyesters such as urethane modified unsaturated polyester, acrylic urethane modified unsaturated polyester, and a liquid unsaturated polyester having an acrylic group as a terminal group.
  • the radiation curing type resin mentioned above may be employed alone or as a mixture of two or more.
  • the preferred polyester type prepolymers according to our invention are in particular the copolymer of ethylene terephthalate and isophthalate.
  • such ethylene terephalate/isophtalate polyester copolymer such as the one commercially available under the trade name Vitel PE 200 for Goodyear Chemicals Akron, Ohio, USA, is in fact a saturated polymer not having two or more unsaturated double bonds which are conventionally a perequisite for obtaining a curable resin composition.
  • Vitel PE 200 for Goodyear Chemicals Akron, Ohio, USA
  • Diluent monomers are used in radiation curable formulations to reduce the viscosity and to increase flow characteristics. These monomers participate in the free radical curing process.
  • reactive diluent monomers there may be exemplified the following mono-functional monomers: methyl (metha) acrylate, ethyl acrylate, butyl acrylate, 2-ethylhexyl methacrylate, 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, glycidyl methacrylate, n-hexyl acrylate, lauryl acrylate, tetrahydrofurfurylmethacrylate etc.
  • di-functional monomers such as 1,6-hexanediol diacrylate, 1,6-hexanediol dimethacrylate, silicone diacrylate, neopentylglycol , 1,4-butanediol diacrylate, ethyleneglycol diacrylate, polyethyleneglycol diacrylate, pentaerythritol diacrylate, divinylbenzene, etc.
  • tri- or more-functional monomers such as trimethylolpropane triacrylate, trimethylolpropane trimethacrylate, pentaerythritol triacrylate, dipentaerythritol hexaacrylate, an acrylate of ethylenediamine, aliphatic and aromatic urethane acrylates, etc. may also be used as diluent monomers in curable compositions suitable for edge-reinforcing radiographic screens without however attaining the objects of our invention.
  • mono-functional monomers are used as diluent monomers as will be illustrated by the examples hereinafter.
  • Preferred mono-functional monomers are the following methacrylate compounds : methylmethacrylate and tetrahydrofurfurylmethacrylate.
  • photoinitiator which is a catalyst to initiate the polymerization by absorption of ultraviolet ray energy
  • photosensitizer for accelerating the effect of the photoinitiator by transferring energy and forming free radicals by interaction.
  • carbonyl compounds may be frequently employed, for example, benzoin ether series compounds such as benzoin isopropyl, isobutylether; benzil ketal series compounds; ketoxime esters; benzophenone series compounds such as benzophenone, o-benzoylmethylbenzoate; acetophenone series compounds such as acetophenone, trichloroacetophenone, 1,1-dichloroacetophenone, 2,2-diethoxyacetophenone, 2,2-dimethoxy-2-phenylacetophenone; thioxanthone series compounds such as 2-chlorothioxanthone, 2-ethylthioxanthone; and compounds such as 2-hydroxy-2-methylpropiophenone, 2-hydroxy-4′-isopropyl-2-methylpropiophenone, 1-hydroxycyclohexylphenylketone; etc.
  • benzoin ether series compounds such as benzoin isopropyl, isobutylether
  • a particularly preferred photoinitiator for incorporation into the curable resin compositions of our invention is 2-hydroxy-2 methyl-1-phenyl-propan-1-one (tradename DAROCUR 1173, supplied by E. Merck, Darmstadt, W. Germany).
  • the above mentioned photopolymerization initiator may be used alone or as a mixture of two or more.
  • the photosensitizer there may be mentioned amine compounds, nitrile compounds and compounds of sulfur, phosphor, nitrogen, chlorine, etc.
  • the coating can be cured by subjecting it to ultraviolet radiation of suitable intensity from medium pressure mercury arc lamps or other sources of ultraviolet radiation.
  • High energy ionizing radiation such as X-rays, gamma rays, beta rays and accelerated electrons can also be used to accomplish curing of the coating.
  • the radiation used should be of a sufficient intensity to penetrate substantially all the way through the coated layer.
  • the total dosage employed should be sufficient to bring about curing of the radiation curable coating composition to form a solid layer.
  • UV radiation is better suited for non-pigmented or slightly pigmented systems having relatively thin films to allow full penetration of the irradiation.
  • polymerization is best achieved by electron beam (EB) curing because EB can penetrate through thicker and opaque films.
  • EB electron beam
  • UV irradiation is usually carried out employing medium pressure mercury arcs or pulsed xenon arcs. These ultraviolet sources usually are equipped with a cooling installation, an installation to remove the produced ozone and a nitrogen inflow to exclude air from the surface of the product to be cured during radiation processing. An intensity of 40 to 120 W/cm in the 200-400 nm region is usually employed. An example of a commercially available ultraviolet source is IST supplied by Strahlentechnik, Oberboihingen, W. Germany.
  • electrocurtain type accelerators There are two types of electron beam accelerators: high energy scanner types and low energy linear-cathode types also called electrocurtain type accelerators. These accelerators are usually equipped with nitrogen inflow. A dose in the range of 0.01 to 10 megarads is employed. Examples of commercially available EB accelerators are PILOT 200 and CB175/60/380 both supplied by Energy Sciences Inc., Geneva, Switzerland.
  • Curing periods may be adjusted to be very short by proper choice of radiation source, photoinitiator and concentration thereof, prepolymer and reactive diluent, distance between the radiation source and the product to be cured. Curing periods of about 1 second duration are possible, especially in thin film applications such as desired, for example, in coatings. For thicker cured products, curing periods up to 5 minutes, preferably 1-2 minutes, are operable.
  • the radiation curable coating may be applied to the edges of the radiographic screen by techniques known per se as described in detail hereinafter in the Examples.
  • Fig. 1 is a diagrammatic representation of a preferred embodiment of a coating device for applying the radiation curable composition of our invention to the edges of a radiographic screen.
  • Figure 2 is a diagrammatic representation of the coating device of figure 1 according to the arrow A of figure 1.
  • a radiographic screen basically comprises a support and a phosphor layer provided thereon, said phosphor layer comprising a binder and a phosphor dispersed therein.
  • a radiographic screen may comprise, and in case of stimulable screens, usually comprises, a protective topcoat.
  • the phosphor used is a fluorescent substance that emits ultraviolet radiation and/or visible light when struck by penetrating X-ray radiation.
  • the phosphor can be selected from a variety of well-known X-ray luminescent phosphors or phosphor particles taught by the prior art.
  • the phosphors include, for example, calcium tungstate, zinc sulfide, zinc cadmium sulfide, zinc oxide and calcium silicate, zinc phosphate, alkali halides, cadmium sulfide, cadmium selenide, cadmium tungstate, magnesium fluoride, zinc fluoride, strontium sulfide, zinc sulfate, barium lead sulfate, barium fluorohalides, and mixtures of two or more of the above.
  • the above phosphors may be activated with, for example, europium, silver, copper, nickel.
  • Phosphors which are particularly suitable for use in high speed X-ray conversion screens are those selected from fluorescent substances containing elements with atomic number 39 or 57 to 71, which include rare earth elements such as yttrium, gadolinium, lanthanum and cerium.
  • rare earth oxysulfide and oxyhalide fluorescing materials activated with other selected rare earths e.g.
  • lanthanum and gadolinium oxybromide and oxychloride activated with terbium, ytterbium or dysprosium, lanthanum and gadolinium oxysulfides activated with terbium, europium, or a mixture of europium and samarium, yttrium oxide activated with gadolinium, europium, terbium or thulium, yttrium oxysulfide activated with terbium or a mixture of terbium and dysprosium, yttrium tantalate doped with small amounts of terbium or strontium or lithium or a mixture thereof and activated with thulium, niobium, europium, gadolinium, neodymium.
  • a fluorescence over the whole visible spectrum can be obtained, so that such combination is particularly useful for recording with silver halide recording elements that have been made spectrally sensitive for light of the whole visible spectrum.
  • a particularly preferred two-layer phosphor combination comprises coating on a support as described hereinafter a first phosphor layer on the basis of (Y,Sr,Li)TaO4.Nb, as disclosed in EP-A-0 202 875, and thereupon a second phosphor layer on the basis of CaWO4.
  • a first phosphor layer on the basis of (Y,Sr,Li)TaO4.Nb, as disclosed in EP-A-0 202 875
  • a second phosphor layer on the basis of CaWO4.
  • To either of these phosphor layers in particular to the first phosphor layer may be added colorants in view of the enhancement of the image sharpness. Suitable colorants for this purpose are disclosed in e.g. EP-0 178 592, US 3 164 719, 1 477 637, Research Disclosure Nr. 21841.
  • a radiographic screen comprising a phosphor layer combination on the basis of CaWO4 and in particular SrYTaO4 is described in EP-A-0 240 272.
  • the stimulable phosphor used in a stimulable X-ray conversion screen refers to a phosphor which can exhibit stimulated fluorescence when irradiated with a stimulating excitation light after X-ray irradiation. From the viewpoint of practical use, the stimulable phosphor is desired to give stimulated emission in the wavelength region of 300 to 700 nm when excited with stimulating rays in the wavelength region of 400 to 900 nm. Alternatively, stimulable phosphors emitting around 600 nm, such as described in US 4825085, can be used.
  • the divalent europium activated alkaline earth metal halide phosphors and rare earth element activated rare earth oxyhalide phosphors are particularly preferred, because these show stimulated emission of high luminance.
  • the stimulable X-ray conversion screen may have a group of stimulable phosphor layers containing one or more stimulable phosphor layers comprising at least one of the stimulable phosphors as mentioned above.
  • the stimulable phosphors to be contained in respective stimulable phosphor layers may be either identical or different.
  • the stimulable phosphors can be used in any conventional particle size range and distribution. It is generally appreciated that sharper images with less noise are realized with smaller mean particle sizes, but light emission efficiency declines with decreasing particle size. Thus, the optimum mean particle size for a given application is a reflection of the balance between imaging speed and image sharpness desired.
  • the stimulable phoshors are in the form of a layer applied to a support, or applied as a self-supporting layer or sheet.
  • the phosphor layer does not have to contain a separate binder, in most applications the phosphor layers contain sufficient binder to give structural coherence to the layer.
  • the binders useful in the practice are those conventionally employed in the art and include proteins such as gelatin, polysaccharides such as dextran, gum arabic, and synthetic polymers such as polyvinyl butyral, polyvinyl acetate, nitrocellulose, ethylcellulose, vinylidene chloride-vinyl chloride copolymer, polyalkyl (meth)acrylate, vinyl chloride-vinyl acetate copolymer, polyurethane, cellulose acetate, cellulose acetate butyrate, polyvinyl alcohol, polystyrene, polyester, etc.
  • binders are disclosed in US 2502529, US 2887379, US 3617285, US 3300310, US 3300311, US 3743833, Research Disclosure 15444.
  • a mixture of two or more of these binders may be used, e.g., a mixture of polyethyl acrylate and cellulose acetobutyrate.
  • the ratio between the binder and the phosphor may be determined according to the characteristics of the aimed radiographic screen and the nature of the phosphor employed. Generally, the ratio therebetween is within the range of from 1:1 to 1:100 (binder:phosphor, by weight), preferably from 1:10 to 1:25.
  • the thickness of the phosphor layer which may differ depending on the sensitivity of the radiographic screen to radiation, the kind of the phosphor, etc., may be within the range of from 10 to 1000 »m, preferably from 50 to 500 »m, more preferably from 150 to 250 »m.
  • Two or more phosphor layers with different thickness and/or different binder:phosphor ratio and/or different phosphor particle size may be used.
  • Radiographic screens in particular those comprising conventional non-stimulable phosphors as described above can also be in the form of gradual screens, i.e. screens having a gradual intensification along their length and/or width. This can be achieved by graduality in the thickness of the phosphor layer or by graduality in the amount of dye capable of absorbing the light emitted by the phosphor, into the protective layer.
  • the support material examples include plastic films such as films of cellulose acetate, polyvinyl chloride, polyvinyl acetate, polyacrylonitrile, polystyrene, polyester, polyethylene terephthalate, polyamide, polyimide, cellulose triacetate and polycarbonate; metal sheets such as aluminum foil and aluminum alloy foil; ordinary papers; baryta paper; resin-coated papers; pigment papers containing titanium dioxide or the like; and papers sized with polyvinyl alcohol or the like.
  • a plastic film is preferably employed as the support material.
  • the plastic film may contain a light-absorbing material such as carbon black, or may contain a light-reflecting material such as titanium dioxide or barium sulfate.
  • the former is appropriate for preparing a high-resolution type radiographic screen, while the latter is appropriate for preparing a high-sensitivity type radiographic screen.
  • Examples of preferred supports include polyethylene terephthalate, clear or blue colored or black colored (e.g., LUMIRROR C, type X30 supplied by Toray Industries, Tokyo, Japan), polyethylene terepthalate filled with TiO2 or with BaSO4.
  • polyethylene terephthalate clear or blue colored or black colored (e.g., LUMIRROR C, type X30 supplied by Toray Industries, Tokyo, Japan), polyethylene terepthalate filled with TiO2 or with BaSO4.
  • These supports may have thicknesses which may differ depending on the material of the support, and may generally be between 60 and 1000 »m, more preferably between 80 and 500 »m from the standpoint of handling.
  • the phosphor layer can be formed on the support, for instance, by the following procedure.
  • Phosphor particles and a binder are added to an appropriate solvent as described hereinafter, and then mixed to prepare a coating dispersion comprising the phosphor particles homogeneously dispersed in the binder solution.
  • Said coating dispersion may further comprise a dispersing agent and plasticizer and filler material as described hereinafter.
  • the coating dispersion containing the phosphor particles and the binder is applied uniformly onto the surface of the support to form a layer of the coating dispersion.
  • the coating procedure may proceed according to any conventional method such as doctor blade coating, dip-coating or roll coating.
  • the coating dispersion After applying the coating dispersion onto the support, the coating dispersion is then heated slowly to dryness so as to complete the formation of a phosphor layer.
  • Examples of the solvent employable in the preparation of the coating dispersion include lower alcohols such as methanol, ethanol, n-propanol and n-butanol; chlorinated hydrocarbons such as methylene chloride and ethylene chloride; ketones such as acetone, butanone, methyl ethyl ketone and methyl isobutyl ketone; esters of lower alcohols with lower aliphatic acids such as methyl acetate, ethyl acetate and butyl acetate; ethers such as dioxane, ethylene glycol monoethylether; methyl glycol; and mixtures of the abovementioned compounds.
  • lower alcohols such as methanol, ethanol, n-propanol and n-butanol
  • chlorinated hydrocarbons such as methylene chloride and ethylene chloride
  • ketones such as acetone, butanone, methyl ethyl ketone and methyl isobutyl
  • the coating dispersion may contain a dispersing agent to improve the dispersibility of the phosphor particles therein, and may contain a variety of additives such as a plasticizer for increasing the bonding between the binder and the phosphor particles in the phosphor layer.
  • dispersing agent examples include ionic and nonionic well-known dispersing agents or combinations thereof, e.g., GAFAC RM 610 (tradename) supplied by General Aniline and Film Company (GAF), New York, USA, being polyoxyethylene (20) sorbitan monopalmitate and monolaurate, polymeric surfactant such as acrylic graft copolymer, PHOSPHOLIPON 90 (tradename) supplied by Nattermann-Phospholipid GmbH, GmbH, W.
  • GAFAC RM 610 (tradename) supplied by General Aniline and Film Company (GAF), New York, USA, being polyoxyethylene (20) sorbitan monopalmitate and monolaurate
  • polymeric surfactant such as acrylic graft copolymer
  • PHOSPHOLIPON 90 tradename
  • silane dispersing agents such as SILANE Z6040 (tradename) supplied by Dow Corning Corporation, Midland, Michigan, USA or glymo 3-glycidyloxypropyl-methoxysilane or organosulfate polysilanes, unsaturated p-aminamide salts and high molecular acid esters such as ANTI TERRA U 80 (tradename) supplied by BYK-Chemie GmbH, Wesel, W. Germany, high molecular unsaturated polyesters. Dispersing agents are added in an amount of 0.05 to 10 % by weight as compared to the phosphor.
  • plasticizer examples include phosphates such as triphenyl phosphate, tricresyl phosphate and diphenyl phosphate; phthalates such as diethyl phthalate and dimethoxyethyl phthalate; glycolates such as ethylphthalyl ethyl glycolate and butylphthalyl butyl glycolate; and polyesters of polyethylene glycols with aliphatic dicarboxylic acids such as polyester of triethylene glycol with adipic acid and polyester of diethylene glycol with succinic acid.
  • phosphates such as triphenyl phosphate, tricresyl phosphate and diphenyl phosphate
  • phthalates such as diethyl phthalate and dimethoxyethyl phthalate
  • glycolates such as ethylphthalyl ethyl glycolate and butylphthalyl butyl glycolate
  • the coating dispersion may also contain a filler (reflecting or absorbing) or may be colored by a colorant capable of absorbing light within the spectrum emitted by the phosphor or capable of absorbing excitation light in the case of a stimulable X-ray conversion screen.
  • colorants include Solvent Orange 71 (Diaresin Red 7), Solvent Violet 32 (Diaresin Violet A), Solvent Yellow 103 (Diaresin Yellow C) and Solvent Green 20 (all four supplied by Mitsubishi Chemical Industries, Japan), Makrolex Rot GS, Makrolex Rot EG, Makrolex Rot E2G, Helioechtgelb 4G and Helioechtgelb HRN (all five supplied by Bayer, Leverkusen, W. Germany), Neozaponfeuerrot G and Zaponechtbraun BE (both supplied by BASF, Ludwigshafen, W. Germany).
  • An ultrasonic treatment can be applied to improve the packing density and to perform the de-aeration of the phosphor-binder combination.
  • the phosphor layer can be provided onto the support by methods other than those given above.
  • the phosphor is initially prepared on a sheet (temporary support) such as a glass plate, metal plate or plastic sheet using the aforementioned coating dispersion and then thus prepared phosphor layer is superposed on the permanent support by pressing or using an adhesive agent.
  • the phosphor layer may be applied to the support by employing a method such as vapor deposition, sputtering, spraying, etc.
  • one or more additional layers are occasionally provided between the support and the phosphor layer, so as to enhance the bonding between the support and the phosphor layer, or to improve the sensitivity of the screen or the quality of an image provided thereby.
  • a subbing layer or an adhesive layer may be provided by coating polymer material such as gelatin over the surface of the support on the phosphor layer side.
  • a light-reflecting layer or a light-absorbing layer may be provided by forming a polymer material layer containing a light-reflecting material such as titanium dioxide or a light-absorbing material such as carbon black. Such a layer may be coated on the support either as a backing layer or interposed between the support and the active layer.
  • One or more of these additional layers may be provided on the support.
  • a protective overcoat may be provided on the surface of the (stimulable) phosphor layer not facing the support.
  • Said protective overcoat may be formed by a process in which a coating liquid containing at least one of a radiation curing type resin is applied onto the face of the (stimulable) phosphor layer and is subjected to irradiation by ultraviolet rays or electron beam to carry out curing of the coating liquid.
  • the monomers and prepolymers in said coating composition are selected in order to provide a crosslinking reaction for forming a solvent insoluble layer having good abrasion resistance.
  • the radiation curing type resin is e.g. an unsaturated polyester or an urethaneacrylate.
  • a vinylmonomer as a reactive diluent, a non-reactive binder, a crosslinking agent, a photoinitiator, a photosensitizer, a storage stabilizer, a colorant, and other additives, and then dispersed therein to prepare the coating liquid for the protective layer.
  • colorants that can be used in the protective layer include MAKROLEX ROT EG, MAKROLEX ROT GS and MAKROLEX ROT E2G, all three supplied by Bayer, Leverkusen, W. Germany.
  • a difunctional acrylate e.g. hexane diol diacrylate is preferably added as reactive diluent in an amount of between 0 and 80 % by weight, preferably between 10 and 30 % by weight. Higher functional acrylates would yield hard and brittle layers.
  • the photoinitiator which needs to be added to the coating solution will to a more or less extent also absorb the light emitted by the phosphor thereby impairing the sensitivity of the radiographic screen, particularly when a phosphor emitting UV or blue light is used.
  • a photoinitiator has to be chosen of which the absorption range overlaps to a minimum degree with the emission range of the phosphor; a preferred photoinitiator is then DAROCUR 1173 as abovementioned.
  • the amount of the photoinitiator used is preferably within the range of 0.01 to 5 parts by weight relative to 100 parts by weight of the prepolymer.
  • the photoinitiator is preferably used in an amount of 0.5 to 3 parts by weight and within the range of 3 to 7 times the amount of the radical-generating compound used.
  • a variety of other optional materials can be included in said surface coating of the radiographic screen, such as materials to reduce static electrical charge accumulation, plasticizers, matting agents, lubricants, defoamers and the like.
  • lubricants examples include silicones such as SURFACTANT 190 supplied by Dow Corning Corporation, Midland, Michigan, USA, fluorine containing compounds such as polytetrafluoroethylene and LANCO WAX supplied by Georg M. Langer & Co., Bremen, W. Germany, waxes such as ACRAWAX supplied by Glyco Products, New York, USA and LANCO GLIDD supplied by Georg M. Langer & Co., Bremen, W. Germany.
  • the lubricants are added in amounts varying between 0.01 and 0.5 % by weight.
  • defoamers examples include LANCO ANTIBUBBLE L and LANCO FOAMSTOP PL both supplied by Georg M. Langer & Co., Bremen, W. Germany.
  • antistats are more commonly included in the radiographic element which comes into contact with the radiographic screen
  • small amounts of conventional antistatics may be added to the topcoat or to the active layer.
  • static electricity is usually built up during the exchange of the film into and out of the area or cassette containing the X-ray screens. This has been known to cause static marks by exposure of the sensitive photographic film. This cannot be tolerated.
  • anionic or cationic antistats e.g. quaternary ammonium salts
  • the thickness of the protective layer formed according to the abovementioned process may be within the range of from 1 to 100 »m, more preferably from 2 to 20 »m.
  • the composition is coated at a suitable wet thickness (preferably between 60 and 100 »m) and cured by subjecting it to radiation which converts it to a solid form.
  • a suitable wet thickness preferably between 60 and 100 »m
  • Any suitable method for coating a thin uniform layer of the composition can be employed. Examples of suitable coating methods include dip coating, air-knife coating, roll coating, extrusion coating, bead coating, curtain coating, and so forth.
  • a radiographic screen provided with a radiation cured coating was prepared as follows.
  • Green emitting gadolinium oxysulfide phosphor (80 % by weight) was predispersed in a low viscous presolution (20 % by weight) of low binder content, together with a dispersant, by stirring for 5 minutes at 1700 rpm.
  • the presolution consisted of 7 % by weight of polyethyl acrylate binder (PLEXISOL B 372 supplied by Röhm GmbH, Darmstadt, W. Germany), 18 % by weight of ethylacetate, 50 % by weight of methyl ethyl ketone, 24,5 % by weight of methylglycol and 0.5 % of GAFAC RM 610 (supplied by GAF, New York, USA).
  • the obtained phosphor dispersion was applied to a black colored subbed polyethylene terepthalate support by doctor blade coating (wet thickness 900 »m). After evaporation of the solvent a phosphor layer of 160 »m thickness was obtained.
  • a radiation curable coating composition comprising 80 % by weight of a mixture of 80 % of an aromatic urethaneacrylate (EBC 220 supplied by UCB, Drogenbos, Belgium) and 20 % of an aliphatic urethaneacrylate (EBC 264 supplied by UCB, Drogenbos, Belgium), 15 % by weight of hexane diol diacrylate (HDDA), 4.5 % by weight of photoinitiator (DAROCUR 1173 supplied by E. Merck, Darmstadt, W. Germany) and 0.5 % by weight of a silicone surfactant. To this composition was added ethanol as solvent in an amount so as to obtain a 25 wt % solution.
  • EBC 220 supplied by UCB, Drogenbos, Belgium
  • EBC 264 supplied by UCB, Drogenbos, Belgium
  • HDDA hexane diol diacrylate
  • DAROCUR 1173 supplied by E. Merck, Darmstadt, W. Germany
  • composition was applied onto the phosphor layer by dip coating (wet thickness about 100 »m). After evaporation of the solvent a topcoat layer having a thickness of 10-15 »m was obtained.
  • the coating was cured by UV radiation using a Labcure Unit supplied by Technigraf GmbH, Grävenwiesbach, W. Germany (O3 removal, air cooling, energy output of 80 W/cm, velocity 5m/min, distance UV source-substrate 11 cm).
  • the radiographic screen prepared according to this procedure is referred to below as (I)
  • a radiation curable coating was prepared comprising 75 % by weight of a mixture of 80 % of an aromatic urethaneacrylate (EBC 220 supplied by UCB, Drogenbos, Belgium) and 20 % of an aliphatic urethaneacrylate (EBC 264 supplied by UCB, Drogenbos, Belgium), and 25 % by weight of hexane diol diacrylate (HDDA); to this composition was added 5 % by weight of photoinitiator (DAROCUR 1173 supplied by E. Merck, Darmstadt, W. Germany) and 0.5 % by weight of a silicone surfactant. The so obtained mixture was dissolved in ethanol so as to obtain a 35 wt % solution.
  • EBC 220 supplied by UCB, Drogenbos, Belgium
  • EBC 264 supplied by UCB, Drogenbos, Belgium
  • HDDA hexane diol diacrylate
  • DAROCUR 1173 supplied by E. Merck, Darmstadt
  • composition was applied onto the edges of the screen (I) as follows :
  • figure 1 is a diagrammatic representation of a preferred embodiment of a coating device for applying the radiation curable composition of our invention to the edges of a radiographic screen.
  • Fig. 2 is a diagrammatic side view according to the arrow A of the coating device of Fig. 1.
  • the screen (4) is shown moving in the peripheral groove (5) of the rotating drum (2).
  • the edges of the screen (4) are wetted by the radiation curable composition in the bath (1).
  • the amount of radiation curable composition adhering to the edges of the screen was determined i.a. by regulating the viscosity of the radiation curable composition, the latter parameter being determined by the amount of solvent added to said composition.
  • the viscosity of the radiation curable solution was optimal for forming an edge-reinforcing coating on the radiographic screen (I) when as aforementioned, ethanol as solvent was added in an amount so as to obtain a 35 weight % solution of the radiation curable composition.
  • the wet thickness of the radiation curable composition transferred to the edges of the screen amounted to approximately 100 micron.
  • the coating was cured by UV radiation using a Labcure Unit supplied by Technigraf GmbH, Grävenwiesbach, W. Germany (O3 removal, air cooling, energy output of 80 W/cm, velocity 5 m/min, distance UV source-edges 11 cm).
  • the edges of the screen (I) prepared according to the procedure described in Example 1 were reinforced by applying a radiation curable composition as described in Example 1 with the difference however that this composition comprised for 75 % by weight of a mixture of 80 % of an aliphatic urethane acrylate (EBC 1290 supplied by UCB, Drogenbos, Belgium) and 20 % of an aliphatic urethane acrylate (EBC 294 supplied by UCB, Drogenbos, Belgium) instead of the mixture of aromatic/aliphatic urethaneacrylates described in Example 1, all other ingredients of the radiation curable coating composition remaining the same as in Example 1.
  • the method of applying said radiation curable composition to the edges of screen (I) was as described in Example 1.
  • the edges of the screen (I) prepared according to the procedure described in Example 1 were reinforced by applying a radiation curable composition comprising 30 % by weight of a polyester copolymer comprising ethylene terephthalate/ethylene isophthalate (Vitel PE 200, supplied by Goodyear Chemicals Akron, Ohio, USA) and 70 % by weight of hexane diol diacrylate.
  • a radiation curable composition comprising 30 % by weight of a polyester copolymer comprising ethylene terephthalate/ethylene isophthalate (Vitel PE 200, supplied by Goodyear Chemicals Akron, Ohio, USA) and 70 % by weight of hexane diol diacrylate.
  • DAROCUR 1173 photoinitiator
  • the method of applying said radiation curable composition to the edges of screen (I) was as described in Example 1.
  • Example 3 The procedure set forth under Example 3 was repeated with the difference however that instead of Vitel PE200, a copolyester copolymer was used being a copolyester of terephthalic acid with oxyethylated, resp. oxypropylated Bisphenol A.
  • the edges of the screen (I) prepared according to the procedure described in Example 1 were reinforced by applying a radiation curable composition comprising 40 % by weight of Vitel PE200 and 60 % by weight of methylmethacrylate (MMA). To this composition was then added 10 % by weight of the photoinitiator DAROCUR 1173 and 0.5 % by weight of a silicone surfacsant.
  • a radiation curable composition comprising 40 % by weight of Vitel PE200 and 60 % by weight of methylmethacrylate (MMA).
  • MMA methylmethacrylate
  • the radiation curable composition was prepared comprising 60 % by weight of tetrahydrofurfurylmethacrylate (THFMA), instead of methylmethacrylate as diluent solvent.
  • THFMA tetrahydrofurfurylmethacrylate
  • edge reinforcing coatings described in the above Examples were radiation curable compositions, the mechanical strength inclusive of the abrasion resistance, of the edges of the screens reinforced by any of the coatings of the examples, was generally satisfactory. However, important differences as to the adhesive properties of the edge reinforcing coating to the edges of the screen were noted. It is clear that when the adhesion of the edge reinforcing coating to the edges of the screen is poor, the edge protective coating tends to easily loose from the edges of the screen and its inherent abrasion resistance effect consequently also vanishes.
  • Peeling test a piece of tape (Tesatape type 4101, supplied by Beiersdorf AG, Hamburg, W. Germany) was applied firmly to the edge reinforcing coating on the edge of the radiograpic screen and subsequently ripped off. The adherence of the edge reinforcing coating onto the edges of the screen was checked visually on the tearing off of the edge reinforcing coating together with the tape. This adherence test was also repeated after the edge reinforcing coating was slightly damaged by deliberately introducing small cuttings into said coating.
  • compositions suitable for forming edge-reinforcing coatings with good adhesion properties to the radiographic screen structure including the base support made of polyethylene terephthalate, the phosphor-binder layer, and a cured protective topcoat said compositions should comprise a polyester type prepolymer dissolved in a diluent mono-functional monomer.
  • a mono-functional monomer is preferably an acrylate compound such as methyl-methacrylate or tetrahydrofurfurylmethacrylate.
  • edge reinforcing layer exceeds 30 micron, it also more easily looses from the edge of the radiographic screen, as such relatively thick layer becomes brittle and hard.
  • the thickness of such edge reinforcing layer therefore should preferably be less than 20 micron, and more than 5 micron so as to have sufficient mechanical strength.

Claims (9)

  1. Röntgenschirm (4) mit einem Träger, einer einen in einem Bindemittel dispergierten fluoreszierenden Leuchstoff enthaltenden Schicht, sowie einer auf die Leuchstoff-Bindemittel-Schicht aufgetragenen schützenden Deckschicht, dadurch gekennzeichnet daß die Ränder des Schirms durch eine strahlungsgehärtete Beschichtung verstärkt sind, die durch Härten einer strahlungshärtbaren Zusammensetzung erhalten wird, die ein Polyestervorpolymeres und ein als Verdünnungsmittel wirkendes monofunktionelles Monomeres enthält.
  2. Röntgenschirm nach Anspruch 1, wobei es sich bei dem monofunktionellen, als Verdünnungsmittel wirkenden Monomeren um ein Methacrylat handelt.
  3. Röntgenschirm nach Anspruch 2, wobei es sich bei dem Methacrylat um Methylmethacrylat oder Tetrahydrofurfurylmethacrylat handelt.
  4. Röntgenschirm nach den vorhergehenden Ansprüchen, wobei es sich bei dem Polyester um ein Copolymeres aus Ethylenterephthalat und Ethylenisophthalat handelt.
  5. Röntgenschirm nach den vorhergehenden Ansprüchen, wobei es sich bei der schützenden Deckschicht über der Leuchtschicht um eine strahlungsgehärtete Beschichtung handelt.
  6. Röntgenschirm nach den vorhergehenden Ansprüchen, wobei die randverstärkte strahlungsgehärtete Beschichtung eine zwischen 5 und 20 Mikron liegende Dicke aufweist.
  7. Röntgenschirm nach den vorhergehenden Ansprüchen, wobei es sich bei dem Träger um einen Polyethylenterephthalatträger handelt.
  8. Röntgenschirm nach den vorhergehenden Ansprüchen, wobei die Strahlungshärtbare Zusammensetzung einen Photoinitiator enthält.
  9. Röntgenschirm nach Anspruch 8, wobei es sich bei dem Photoinitiator um 2-Hydroxy-2-methyl-1-phenyl-propan-1-on handelt.
EP19920200528 1991-03-08 1992-02-24 Röntgenschirm mit randverstärkender Schicht Expired - Lifetime EP0503702B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19920200528 EP0503702B1 (de) 1991-03-08 1992-02-24 Röntgenschirm mit randverstärkender Schicht

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91200511 1991-03-08
EP91200511 1991-03-08
EP19920200528 EP0503702B1 (de) 1991-03-08 1992-02-24 Röntgenschirm mit randverstärkender Schicht

Publications (2)

Publication Number Publication Date
EP0503702A1 EP0503702A1 (de) 1992-09-16
EP0503702B1 true EP0503702B1 (de) 1995-05-24

Family

ID=26129190

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920200528 Expired - Lifetime EP0503702B1 (de) 1991-03-08 1992-02-24 Röntgenschirm mit randverstärkender Schicht

Country Status (1)

Country Link
EP (1) EP0503702B1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10313984A1 (de) * 2003-03-27 2004-10-28 Siemens Ag Verfahren zur Herstellung eines Bildwandlers mit einer Röntgenkonverterschicht

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2618596B2 (ja) * 1991-07-08 1997-06-11 ローン−プーラン・ロレ・ソシエテ・アノニム タキサン類の誘導体を基とする新規組成物
DE69301867T2 (de) * 1992-06-16 1996-10-02 Agfa Gevaert Nv Röntgenschirm
EP0686927A1 (de) 1994-06-10 1995-12-13 Agfa-Gevaert N.V. System zur Lieferung eines verarbeiteten radiographischen Bildes an einen entfernten Vorrichtung
EP0710015B1 (de) 1994-10-27 1998-09-16 AGFA-GEVAERT naamloze vennootschap Leistungsprüfung für Systeme zum Auslesen von photostimulierbarem Leuchtstoff
EP0767576A1 (de) 1995-10-05 1997-04-09 Agfa-Gevaert N.V. Verfahren zum Herstellen von Dias von radiographischen Bildern
EP0768790A1 (de) 1995-10-09 1997-04-16 Agfa-Gevaert N.V. Reproduktion medizinischer Bilder auf bahnförmigem Aufzeichnungsmaterial
US5812276A (en) * 1995-10-09 1998-09-22 Agfa-Gevaert Reproduction of medical image on web-like reproducing material
US6271536B1 (en) 1997-10-08 2001-08-07 Agfa-Gevaert Radiographic image identification method
EP0915483A1 (de) * 1997-11-05 1999-05-12 Imation Corp. Verbesserte radiographische Schirm-Konstruktion
US6844056B2 (en) 2001-12-03 2005-01-18 Agfa-Gevaert Binderless storage phosphor screen having fluoro-containing moieties
EP1316970A1 (de) * 2001-12-03 2003-06-04 Agfa-Gevaert Binderfreier Speicherleuchtschirm mit fluorhaltigen Verbindungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54107691A (en) * 1978-02-10 1979-08-23 Dainippon Toryo Kk Method of fabricating radiant ray intensifying paper
CA1270407A (en) * 1984-04-06 1990-06-19 Kaoru Tamura Stimulable, phosphor-sheet, and method and device of conveying the same
US4684592A (en) * 1984-04-06 1987-08-04 Fuji Photo Film Co., Ltd. Stimulable phosphor sheet
JPS623700A (ja) * 1985-06-28 1987-01-09 富士写真フイルム株式会社 放射線像変換パネル
US4835397A (en) * 1986-04-19 1989-05-30 Fuji Photo Film Co., Ltd. Radiation image storage panel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10313984A1 (de) * 2003-03-27 2004-10-28 Siemens Ag Verfahren zur Herstellung eines Bildwandlers mit einer Röntgenkonverterschicht

Also Published As

Publication number Publication date
EP0503702A1 (de) 1992-09-16

Similar Documents

Publication Publication Date Title
EP0209358B1 (de) Schirm zum Speichern eines Strahlungsbildes
US5164224A (en) Radiation image storage panel radiographic intensifying screen and processes for the preparation of the same
EP0083470B1 (de) Schirm zum Speichern eines Strahlungsbildes
JP3150432B2 (ja) Ｘ線変換スクリーン
EP0503702B1 (de) Röntgenschirm mit randverstärkender Schicht
US5340661A (en) Radiographic screen with edge-reinforcing coating
US6120902A (en) Luminescent article with protective coating and manufacture
US5663005A (en) Self-supporting or supported phosphor screen or panel
JP3365830B2 (ja) 改良された速度／像品質関係を有するｘ線増感スクリーン
JP2549911B2 (ja) 放射線像変換パネルとその製造法
EP0133683B1 (de) Schirm zum Speichern eines Strahlungsbildes
US6221516B1 (en) Radiation image storage panel
US20020043627A1 (en) X-ray luminescent article offering improved film sharpness
US4788435A (en) Radiation image storage panel
EP0448161B1 (de) Verfahren zur Verbesserung der Haftung an strahlungsgehärteten Schichten
JPH0631892B2 (ja) 放射線画像変換媒体
EP0967620B1 (de) Röntgenleuchtartikel mit verbesserter Filmschärfe
EP0092241B1 (de) Strahlungsbildwandler
EP0520094A1 (de) Röntgenstrahlen-Leuchtstoffzusammensetzung für Röntgenstrahlen Verstärkersfoelie
JP2996622B2 (ja) 自己支持又は被支持リン光体スクリーン又はパネル
JPS5935000B2 (ja) 放射線像変換用パネル
JPS6215498A (ja) 放射線画像変換パネル
JPH0843598A (ja) 放射線画像変換媒体

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE DE FR GB

17P Request for examination filed

Effective date: 19930204

17Q First examination report despatched

Effective date: 19940725

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE DE FR GB

REF Corresponds to:

Ref document number: 69202595

Country of ref document: DE

Date of ref document: 19950629

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19980120

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990228

REG Reference to a national code

Ref country code: GB

Ref legal event code: 746

Effective date: 19990204

REG Reference to a national code

Ref country code: FR

Ref legal event code: D6

BERE Be: lapsed

Owner name: AGFA-GEVAERT N.V.

Effective date: 19990228

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20060119

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20060124

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20070126

Year of fee payment: 16

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20071030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070228

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20080224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080224